- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Glabellar Crease
Total 10000 results
-
National Cancer Institute (NCI)CompletedHER2/Neu Positive | Ductal Breast Carcinoma In SituUnited States
-
Mayo ClinicNational Cancer Institute (NCI)WithdrawnAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic... and other conditions
-
Zhejiang Cancer HospitalNot yet recruitingAdvanced Breast Cancer | HER2-negative Breast Cancer
-
University Hospital, Basel, SwitzerlandSwiss National Science FoundationActive, not recruitingBreast Reconstruction | Implant-Based Breast Reconstruction (IBBR)Austria, Sweden, Germany, Hungary, Switzerland, United States, Italy
-
National Cancer Institute (NCI)Active, not recruitingBreast Carcinoma In Situ | Breast Ductal Carcinoma In Situ | Breast Lobular Carcinoma In Situ | Stage I Breast Cancer AJCC v7 | Stage IA Breast Cancer AJCC v7 | Stage IB Breast Cancer AJCC v7 | Stage II Breast Cancer AJCC v6 and v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC... and other conditionsUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedSedentary Lifestyle | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC... and other conditionsUnited States
-
Hu HaiZhejiang Cancer HospitalNot yet recruiting
-
University Hospital HeidelbergRecruiting
-
Delcath Systems Inc.RecruitingMetastatic Breast Cancer in the LiverUnited States, Italy
-
Shu WangRecruitingHER2-positive Breast CancerChina
-
SciClone PharmaceuticalsRecruitingAdvanced Breast Cancer | ESR1 Gene MutationChina
-
MediLink Therapeutics (Suzhou) Co., Ltd.RecruitingLocally Advanced or Metastatic Breast CancerChina
-
Yun-Chen ChangChina Medical University, ChinaNot yet recruitingBreast Cancer | Randomized Controlled Trial | Breast Cancer FemaleTaiwan
-
Institute of Cancer Research, United KingdomCase45 LtdNot yet recruitingTriple Negative Breast Cancer
-
Shengjing HospitalJiangsu HengRui Medicine Co., Ltd.RecruitingHR Positive/HER2 Low Breast CancerChina
-
Mennatallah Arous MohamedRecruitingBreast Carcinoma Metastatic in Lymph NodeEgypt
-
Samsung Medical CenterRecruitingBreast Cancer | Metastatic Breast Cancer | Radiation Therapy ComplicationKorea, Republic of
-
Shanghai Pharmaceuticals Holding Co., LtdRecruitingLocally Advanced or Metastatic Breast CancerChina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot yet recruitingBreast Carcinoma; Magnetic Resonance Imaging;OGSEChina
-
Fudan UniversityRecruitingMetastatic Breast Cancer in the LiverChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingHormone Receptor Positive Advanced Breast CancerChina
-
Gencurix, Inc.RecruitingEarly Hormone Receptor-positive Breast CancerKorea, Republic of
-
UNICANCERPfizerActive, not recruitingSurgery | Breast Cancer Stage IV | RadiotherapyFrance
-
Duke UniversitySuspendedBreast Cancer | Weight Management | Breast Cancer Survivorship | Cardiovascular (CV) RiskUnited States
-
Hoffmann-La RocheActive, not recruitingLocally Advanced or Metastatic Breast CancerUnited States, Spain, Taiwan, France, Argentina, Belgium, China, Germany, Saudi Arabia, Thailand, United Kingdom, Colombia, Poland, India, Portugal, Hungary, Mexico, Lebanon, Jordan, Kenya, Brazil, Italy, Oman, Egypt, South Korea, Turkey... and more
-
AstraZenecaApices Soluciones S.L.; SOLTI Breast Cancer Research GroupActive, not recruiting
-
Institute of Oncology LjubljanaCompletedBreast Cancer | Breast Lesions of Uncertain Malignant Potential (B3 Lesions)Slovenia
-
Sermonix Pharmaceuticals Inc.Linical Accelovance GroupCompletedLocally Advanced or Metastatic Breast CancerUnited States, Canada, Israel
-
DualityBio Inc.BioNTech SEActive, not recruiting
-
UNICANCERNational Cancer Institute, FranceActive, not recruitingTriple-Negative Breast NeoplasmFrance
-
Chongqing General HospitalActive, not recruitingNeoadjuvant Therapy | HER2 Positive Breast CarcinomaChina
-
Genexine, Inc.Merck Sharp & Dohme LLCCompletedTriple Negative Breast CancerKorea, Republic of
-
Mahdis BayatCompletedHER2 Low Breast Carcinoma
-
Stemline Therapeutics, Inc.CompletedAdvanced ER+, HER2-Negative Breast CancerUnited States
-
CelltrionNippon Kayaku Co., Ltd.CompletedHER2-positive Carcinoma of BreastItaly, South Africa, Mexico, Japan, Taiwan, Russian Federation, Philippines, Hungary, Romania, Spain, Bosnia and Herzegovina, India, Peru, Ukraine, Latvia, Argentina, Georgia, Belarus, Chile, France, Poland, Portugal
-
Novartis PharmaceuticalsTerminatedAdvanced or Metastatic ER+ Breast CancerUnited States, France, Germany, Singapore, Italy, Japan, Belgium
-
University of BergenHaukeland University HospitalActive, not recruitingStage III Breast Cancer AJCC V7Norway
-
Medstar Health Research InstituteGenentech, Inc.TerminatedHER-2 Positive Metastatic Breast CancerUnited States
-
University of ArizonaCompletedEstrogen Levels Among Breast Cancer PatientsUnited States
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors, Excluding Breast CancerUnited States
-
Novartis PharmaceuticalsCompletedAdvanced or Metastatic Breast CancerSpain, United States
-
Genor Biopharma Co., Ltd.UnknownHER-2-positive Advanced Breast CancerChina
-
The Netherlands Cancer InstituteDutch Cancer SocietyCompletedBreast Cancer Survivors | Climacteric SymptomsNetherlands
-
Novartis PharmaceuticalsCompletedOestrogen Receptor Positive Advanced Breast CancerUnited Kingdom
-
Janssen Research & Development, LLCCompletedPostmenopausal | Metastatic ER+ Her2- Breast CancerUnited States, France, Ukraine, United Kingdom, Belgium, Spain, Netherlands, Korea, Republic of, Russian Federation, Poland, Luxembourg, Ireland
-
Novartis PharmaceuticalsChugai PharmaceuticalCompletedPostmenopausal Women With Advanced Breast CancerJapan
-
Mount Mary UniversityCompletedBreast Cancer Female | SurvivorshipUnited States
-
iOMEDICO AGCompleted
-
Guangdong Provincial People's HospitalCompletedHighly Endocrine Responsive Operable Breast CancerChina
-
Columbia UniversityWyeth is now a wholly owned subsidiary of Pfizer; Genentech, Inc.CompletedTriple Negative Breast CancerUnited States